
At CFS 2026, Martin Gleave, CM, MD, FRCSC, FACS, explained why higher-volume, high-grade prostate cancer is the sweet spot for perioperative ARPI therapy.
How much do you know about the incidence and screening of prostate cancer? Here's your chance to find out.
In this quiz, you’ll get a chance to test your knowledge of incidence and screening in prostate cancer. Here’s your first question:
1. Nearly half of U.S. prostate cancer deaths occur in men diagnosed after the age of ____.
A.74 years
B.76 years
C.78 years
D.80 years






